160 related articles for article (PubMed ID: 8971280)
1. Review article: methotrexate in gastroenterology--dangerous villain or simply misunderstood?
Tang H; Neuberger J
Aliment Pharmacol Ther; 1996 Dec; 10(6):851-8. PubMed ID: 8971280
[TBL] [Abstract][Full Text] [Related]
2. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
Lanse SB; Arnold GL; Gowans JD; Kaplan MM
Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
[TBL] [Abstract][Full Text] [Related]
3. [Liver damage in methotrexate-treated patients. When liver biopsy is necessary in the follow-up?].
Nieminen U; Höök-Nikanne J; Kärkkäinen P; Niemelä S
Duodecim; 2005; 121(24):2680-8. PubMed ID: 16454249
[No Abstract] [Full Text] [Related]
4. Monitoring patients taking methotrexate for hepatotoxicity. Does the standard of care match published guidelines?
Petrazzuoli M; Rothe MJ; Grin-Jorgensen C; Ramsey WH; Grant-Kels JM
J Am Acad Dermatol; 1994 Dec; 31(6):969-77. PubMed ID: 7962779
[TBL] [Abstract][Full Text] [Related]
5. Longterm methotrexate therapy in rheumatoid arthritis: a review.
Kremer JM
J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of liver fibrosis by transient elastography in methotrexate treated patients.
Barbero-Villares A; Mendoza J; Trapero-Marugan M; Gonzalez-Alvaro I; Daudén E; Gisbert JP; Moreno-Otero R
Med Clin (Barc); 2011 Nov; 137(14):637-9. PubMed ID: 21719043
[TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity of methotrexate in rheumatic diseases.
Kevat S; Ahern M; Hall P
Med Toxicol Adverse Drug Exp; 1988; 3(3):197-208. PubMed ID: 3041245
[TBL] [Abstract][Full Text] [Related]
8. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
Sante; 2001; 11(3):195-200. PubMed ID: 11641084
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate Hepatotoxicity Monitoring Guidelines in Psoriasis and Rheumatoid Arthritis: Is There a Consensus?
Clary DD; Reid AT; Kiani R; Fanciullo J
S D Med; 2021 Aug; 74(8):363-366. PubMed ID: 34461001
[TBL] [Abstract][Full Text] [Related]
10. Low-dose methotrexate in primary biliary cirrhosis.
Bonis PA; Kaplan MM
Gastroenterology; 1999 Dec; 117(6):1510-3. PubMed ID: 10610345
[No Abstract] [Full Text] [Related]
11. Short term efficacy of methotrexate in the treatment of rheumatoid arthritis.
Willkens RF
J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():21-4. PubMed ID: 3913772
[TBL] [Abstract][Full Text] [Related]
12. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Amital H; Arnson Y; Chodick G; Shalev V
Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.
Shergy WJ; Polisson RP; Caldwell DS; Rice JR; Pisetsky DS; Allen NB
Am J Med; 1988 Dec; 85(6):771-4. PubMed ID: 3195601
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxicty of Agents Used in the Management of Inflammatory Bowel Disease: a 2020 Update.
Barnhill MS; Steinberg JM; Jennings JJ; Lewis JH
Curr Gastroenterol Rep; 2020 Jul; 22(9):47. PubMed ID: 32671616
[TBL] [Abstract][Full Text] [Related]
15. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.
Prey S; Paul C
Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303
[TBL] [Abstract][Full Text] [Related]
16. Low-dose methotrexate therapy and hepatotoxicity. The view of the hepatologist.
Watson RG; Smallwood RA
Med J Aust; 1991 Oct; 155(7):428-30. PubMed ID: 1921807
[No Abstract] [Full Text] [Related]
17. [Methotrexate in therapy of gastrointestinal diseases].
Schröder O; Stein J
Z Gastroenterol; 1999 Jul; 37(7):623-37. PubMed ID: 10458012
[TBL] [Abstract][Full Text] [Related]
18. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
Te HS; Schiano TD; Kuan SF; Hanauer SB; Conjeevaram HS; Baker AL
Am J Gastroenterol; 2000 Nov; 95(11):3150-6. PubMed ID: 11095334
[TBL] [Abstract][Full Text] [Related]
19. [Methotrexate therapy of inflammatory diseases. Reliable effects and recent developments in rheumatology, pneumology, gastroenterology and dermatology].
Schnabel A; Dalhoff K; Stange EF; Mrowietz U; Gross WL
Med Klin (Munich); 1995 Jun; 90(6):364-71. PubMed ID: 7637668
[No Abstract] [Full Text] [Related]
20. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Palmer HM
Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
[No Abstract] [Full Text] [Related]
[Next] [New Search]
